The Groupe d’Etude sur les Affections Inflammatoires Digestives (GETAID): 40 Years of a Family Story in Inflammatory Bowel Disease - Takeaways - MDSpire

The Groupe d’Etude sur les Affections Inflammatoires Digestives (GETAID): 40 Years of a Family Story in Inflammatory Bowel Disease

  • By

  • David Laharie

  • Lucine Vuitton

  • Arnaud Bourreille

  • Yoram Bouhnik

  • Jean-Frédéric Colombel

  • Edouard Louis

  • Mathurin Fumery

  • Charlotte Mailhat

  • Jean-Yves Mary

  • Laurent Peyrin-Biroulet

  • August 29, 2024

  • 0 min

Share

  • 1

    GETAID was founded in 1983 to address clinical questions in inflammatory bowel disease through innovative research methods.

  • 2

    The group has published over 120 original articles in peer-reviewed journals, significantly advancing knowledge in inflammatory bowel diseases.

  • 3

    GETAID's early research included a landmark trial evaluating levamisole for Crohn's disease, highlighting its commitment to relevant clinical questions.

  • 4

    The organization operates through regular meetings to discuss and develop collaborative projects in inflammatory bowel disease.

  • 5

    GETAID established the Crohn’s Disease Endoscopic Index of Severity, demonstrating the importance of quantifying disease severity in clinical trials.

Original Source(s)

The Groupe d’Etude sur les Affections Inflammatoires Digestives (GETAID): 40 Years of a Family Story in Inflammatory Bowel Disease

  • by David Laharie, Lucine Vuitton, Arnaud Bourreille, Yoram Bouhnik, Jean-Frédéric Colombel, Edouard Louis, Mathurin Fumery, Charlotte Mailhat, Jean-Yves Mary, Laurent Peyrin-Biroulet

  • August 29, 2024

Related Content

Assessment of the quality and dependability of Crohn's disease-related information on Douyin and Xiaohongshu: Insights from user feedback in a cross-sectional analysis

Metabolic and Structural Alterations Linked to Mice's Vulnerability to Primary Echinostoma caproni Infections

Side Effects: Four Studies Worth Passing On

Kissing celiacs, Ozempic genes, Viagra for the brain, and a UTI test that actually works. This week's evidence is weird, useful, and worth your time.